Annual CFI
$34.75 M
+$250.35 M+116.12%
December 31, 2023
Summary
- As of February 8, 2025, SWTX annual cash flow from investing activities is $34.75 million, with the most recent change of +$250.35 million (+116.12%) on December 31, 2023.
- During the last 3 years, SWTX annual CFI has risen by +$453.59 million (+108.30%).
- SWTX annual CFI is now -58.42% below its all-time high of $83.59 million, reached on December 31, 2021.
Performance
SWTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$28.65 M
+$28.36 M+9812.80%
September 30, 2024
Summary
- As of February 8, 2025, SWTX quarterly cash flow from investing activities is $28.65 million, with the most recent change of +$28.36 million (+9812.80%) on September 30, 2024.
- Over the past year, SWTX quarterly CFI has increased by +$28.36 million (+9812.80%).
- SWTX quarterly CFI is now -70.95% below its all-time high of $98.60 million, reached on March 31, 2023.
Performance
SWTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$108.81 M
-$5.95 M-5.79%
September 30, 2024
Summary
- As of February 8, 2025, SWTX TTM cash flow from investing activities is -$108.81 million, with the most recent change of -$5.95 million (-5.79%) on September 30, 2024.
- Over the past year, SWTX TTM CFI has dropped by -$5.95 million (-5.79%).
- SWTX TTM CFI is now -155.63% below its all-time high of $195.59 million, reached on September 30, 2022.
Performance
SWTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SWTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +116.1% | +9812.8% | -5.8% |
| 3 y3 years | +108.3% | +9812.8% | -5.8% |
| 5 y5 years | +10000.0% | +9812.8% | -5.8% |
SWTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.4% | +116.1% | -71.0% | +108.1% | -155.6% | +49.5% |
| 5 y | 5-year | -58.4% | +108.3% | -71.0% | +108.1% | -155.6% | +75.8% |
| alltime | all time | -58.4% | +108.3% | -71.0% | +108.1% | -155.6% | +75.8% |
SpringWorks Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $28.65 M(+9812.8%) | -$108.81 M(+5.8%) |
| Jun 2024 | - | $289.00 K(-98.7%) | -$102.85 M(+142.7%) |
| Mar 2024 | - | $21.46 M(-113.5%) | -$42.39 M(-222.0%) |
| Dec 2023 | $34.75 M(-116.1%) | -$159.21 M(-560.1%) | $34.75 M(-121.6%) |
| Sep 2023 | - | $34.60 M(-43.1%) | -$161.05 M(+47.2%) |
| Jun 2023 | - | $60.76 M(-38.4%) | -$109.42 M(-23.7%) |
| Mar 2023 | - | $98.60 M(-127.8%) | -$143.42 M(-33.5%) |
| Dec 2022 | -$215.60 M(-357.9%) | -$355.01 M(-511.7%) | -$215.60 M(-210.2%) |
| Sep 2022 | - | $86.23 M(+222.3%) | $195.59 M(+34.8%) |
| Jun 2022 | - | $26.76 M(+1.3%) | $145.15 M(+3.0%) |
| Mar 2022 | - | $26.42 M(-53.0%) | $140.93 M(+68.6%) |
| Dec 2021 | $83.59 M | $56.18 M(+57.0%) | $83.59 M(-142.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $35.78 M(+58.7%) | -$195.37 M(-45.5%) |
| Jun 2021 | - | $22.54 M(-172.9%) | -$358.72 M(-20.2%) |
| Mar 2021 | - | -$30.92 M(-86.1%) | -$449.59 M(+7.3%) |
| Dec 2020 | -$418.83 M(+9731.7%) | -$222.78 M(+74.6%) | -$418.83 M(+113.5%) |
| Sep 2020 | - | -$127.56 M(+86.7%) | -$196.18 M(+185.6%) |
| Jun 2020 | - | -$68.33 M(>+9900.0%) | -$68.70 M(+1551.9%) |
| Mar 2020 | - | -$160.00 K(+23.1%) | -$4.16 M(-2.4%) |
| Dec 2019 | -$4.26 M(+1353.9%) | -$130.00 K(+54.8%) | -$4.26 M(+3.1%) |
| Sep 2019 | - | -$84.00 K(-97.8%) | -$4.13 M(+2.1%) |
| Jun 2019 | - | -$3.79 M(+1350.2%) | -$4.05 M(+1450.2%) |
| Mar 2019 | - | -$261.00 K | -$261.00 K |
| Dec 2018 | -$293.00 K | - | - |
FAQ
- What is SpringWorks Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics annual CFI year-on-year change?
- What is SpringWorks Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics quarterly CFI year-on-year change?
- What is SpringWorks Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics TTM CFI year-on-year change?
What is SpringWorks Therapeutics annual cash flow from investing activities?
The current annual CFI of SWTX is $34.75 M
What is the all time high annual CFI for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high annual cash flow from investing activities is $83.59 M
What is SpringWorks Therapeutics annual CFI year-on-year change?
Over the past year, SWTX annual cash flow from investing activities has changed by +$250.35 M (+116.12%)
What is SpringWorks Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of SWTX is $28.65 M
What is the all time high quarterly CFI for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high quarterly cash flow from investing activities is $98.60 M
What is SpringWorks Therapeutics quarterly CFI year-on-year change?
Over the past year, SWTX quarterly cash flow from investing activities has changed by +$28.36 M (+9812.80%)
What is SpringWorks Therapeutics TTM cash flow from investing activities?
The current TTM CFI of SWTX is -$108.81 M
What is the all time high TTM CFI for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high TTM cash flow from investing activities is $195.59 M
What is SpringWorks Therapeutics TTM CFI year-on-year change?
Over the past year, SWTX TTM cash flow from investing activities has changed by -$5.95 M (-5.79%)